New Research Study Using CGM and a Basal Insulin Calculator for Adults with Type 2 Diabetes

About The Study

Do you have Type 2 Diabetes and use (or are willing to start) basal insulin? You may qualify for a research study evaluating a new glucose monitoring system.

This study is designed to evaluate how an FDA-cleared CGM system and basal insulin dose calculator work, and to confirm it is safe to use. Participants will wear the study CGM device and use a mobile app that provides daily insulin dose recommendations for approximately 4 months. Weekly telephone check-ins are also included.

To take part in the study, participants should:

  • Have been diagnosed with Type 2 Diabetes
  • Be currently using Glargine U-100 basal insulin, or willing to start
  • Be 18 years of age or older
  • Be willing to wear the study provided CGM system
  • Be willing to receive and follow daily basal insulin dose recommendations through the study app
See if you qualify
Study Image

What Is a Study?

  • A clinical study helps advance the future of diabetes! Research patients try new meds or devices not yet available to the public, at no cost to them.
  • Research patients meet with a study coordinator and doctor multiple times to monitor them.
  • Each visit, patients are compensated for travel expenses.
  • Study patients must meet a list of criteria in order to be a part of a study.
  • A study can last anywhere from six months to a few years.

Join this study!

If you want to see if you qualify for a study, share your information and we will contact you. Want to speak with someone immediately? Call (515) 329-5690.

Please enter your first name.
Please enter your last name.
Please enter a valid phone number.
Please enter a valid email address.

Benefits


Receive free medications and free supplies!

Gain better understanding of your disease and take an active role in your health.

Obtain treatments not yet available and contribute to medical research.

Travel stipends for attending most scheduled research appointments.

On average patients receives free care worth $250 - $500 from diabetes experts.

So far Iowa Diabetes Research has spent more than $500K on patients benefits

Our Caring Team

Anuj Bhargava

Dr. Anuj Bhargava

CEO and Medical Director

Tara Herrold

Tara Herrold

Director of Clinical Research

Natalie Young

Natalie Young

Clinical Research Coordinator

Kendra Ridenour

Kendra Ridenour

Navigator/Study Start-up Manager

Kara Turner

Kara Turner

Clinical Research Coordinator

Allie Fowler

Allie Bohr

Clinical Research Coordinator